How to buy Stryker Corporation stock (SYK)

Stryker Corporation is a medical devices business based in the US. Stryker Corporation shares (SYK) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $357.14 – a decrease of 4.66% over the previous week. Stryker Corporation employs 52,000 staff and has a trailing 12-month revenue of around $22 billion.

Our top picks for where to buy Stryker Corporation stock

Buy Stryker Corporation stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Stryker Corporation stock price (NYSE: SYK)

Use our graph to track the performance of SYK stocks over time.

Stryker Corporation shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$357.14
52-week range	$290.43 - $398.20
50-day moving average more info button	$373.56
200-day moving average more info button	$351.29
Wall St. target price	$404.78
PE ratio more info button	38.455
Dividend yield more info button	$3.2 (0.94%)
Earnings per share (TTM) more info button	$9.34

Is it a good time to buy Stryker Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Stryker Corporation price performance over time

Historical closes compared with the close of $359.17 from 2024-12-18

1 week (2024-12-13)	-4.12%
1 month (2024-11-20)	-6.87%
3 months (2024-09-19)	-1.61%
6 months (2024-06-18)	3.01%

1 year (2023-12-20)	24.58%
2 years (2022-12-19)	53.40%
3 years (2021-12-20)	49.78%
5 years (2019-12-20)	80.73%

Is Stryker Corporation stock undervalued or overvalued?

Valuing Stryker Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Stryker Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Stryker Corporation's P/E ratio

Stryker Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 38x. In other words, Stryker Corporation shares trade at around 38x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Stryker Corporation's PEG ratio

Stryker Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.5081. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Stryker Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Stryker Corporation's EBITDA

Stryker Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $5.7 billion.

The EBITDA is a measure of a Stryker Corporation's overall financial performance and is widely used to measure a its profitability.

Stryker Corporation financials

Revenue TTM	$22 billion
Operating margin TTM	21.59%
Gross profit TTM	$11.6 billion
Return on assets TTM	7.11%
Return on equity TTM	18.87%
Profit margin	16.34%
Book value	$52.86
Market Capitalization more info button	$136.9 billion

TTM: trailing 12 months

Stryker Corporation's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Stryker Corporation.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Stryker Corporation's total ESG risk score

Total ESG risk: 33.93

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Stryker Corporation's overall score of 33.93 (as at 12/31/2018) is pretty weak – landing it in it in the 71st percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Stryker Corporation is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Stryker Corporation's environmental score

Environmental score: 3.06/100

Stryker Corporation's environmental score of 3.06 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Stryker Corporation is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Stryker Corporation's social score

Social score: 14.68/100

Stryker Corporation's social score of 14.68 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Stryker Corporation is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Stryker Corporation's governance score

Governance score: 8.19/100

Stryker Corporation's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Stryker Corporation is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Stryker Corporation's controversy score

Controversy score: 3/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Stryker Corporation scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Stryker Corporation hasn't always managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

Stryker Corporation was last rated for ESG on: 2019-01-01.

Total ESG score	33.93
Total ESG percentile	70.66
Environmental score	3.06
Environmental score percentile	1
Social score	14.68
Social score percentile	1
Governance score	8.19
Governance score percentile	1
Level of controversy	3

Stryker Corporation share dividends

Dividend payout ratio: 27.49% of net profits

Recently Stryker Corporation has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Stryker Corporation shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Stryker Corporation's case, that would currently equate to about $3.2 per share.

While Stryker Corporation's payout ratio might seem fairly standard, it's worth remembering that Stryker Corporation may be investing much of the rest of its net profits in future growth.

Stryker Corporation's most recent dividend payout was on 30 January 2025. The latest dividend was paid out to all shareholders who bought their shares by 30 December 2024 (the "ex-dividend date").

Have Stryker Corporation's shares ever split?

Stryker Corporation's shares were split on a 2:1 basis on 16 May 2004 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Stryker Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Stryker Corporation shares which in turn could have impacted Stryker Corporation's share price.

Stryker Corporation share price volatility

Over the last 12 months, Stryker Corporation's shares have ranged in value from as little as $290.4305 up to $398.2. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Stryker Corporation's is 0.92. This would suggest that Stryker Corporation's shares are less volatile than average (for this exchange).

Stryker Corporation overview

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries.

Frequently asked questions

What percentage of Stryker Corporation is owned by insiders or institutions?
Currently 5.378% of Stryker Corporation shares are held by insiders and 80.511% by institutions. How many people work for Stryker Corporation?
Latest data suggests 52,000 work at Stryker Corporation. When does the fiscal year end for Stryker Corporation?
Stryker Corporation's fiscal year ends in December. Where is Stryker Corporation based?
Stryker Corporation's address is: 1941 Stryker Way, Portage, MI, United States, 49002 What is Stryker Corporation's ISIN number?
Stryker Corporation's international securities identification number is: US8636671013 What is Stryker Corporation's CUSIP number?
Stryker Corporation's Committee on Uniform Securities Identification Procedures number is: 863667101